
Buy LL-37 Research Peptide
Supplied as a lyophilized powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis.

Buy LL-37 Research Peptide
Supplied as a lyophilized powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis.
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA Available
Every batch
Ships Next Day
Orders confirmed before 12pm EST ship the same business day; orders after 12pm EST ship the next business day. Monday to Friday.
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA Available
Every batch
Ships Next Day
Orders confirmed before 12pm EST ship the same business day; orders after 12pm EST ship the next business day. Monday to Friday.
Verify Batch
Lot-level COA, Batch DF/LL3/062026
What is LL-37?
LL-37 is the body's only peptide of its kind (a cathelicidin), made by skin, immune and lining cells as part of natural defense. It is studied in laboratory research for its antimicrobial activity and its effects on immune signaling and wound repair.
- The only antimicrobial peptide of its class made naturally by the human body
- Released by immune and skin cells as part of first-line defense against microbes
- Studied for antimicrobial activity against Gram-positive and Gram-negative bacterial species and for inhibiting bacterial biofilm formation
- Investigated in wound-repair studies and for its effects on immune-cell signaling
For research use only. Not approved for human therapeutic use.
LL-37 (CAS 154947-66-7) is a synthetic 37-amino acid peptide and the sole cathelicidin-derived antimicrobial peptide identified in humans. With a molecular weight of 4493.34 g/mol, LL-37 is defined by the amino acid sequence LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES, a highly cationic, amphipathic alpha-helical peptide derived from the C-terminal cleavage of the 18 kDa precursor protein hCAP-18. Its name reflects the two leucine residues at the N-terminus and its 37-residue length. The amphipathic structure with clustered cationic and hydrophobic faces along the alpha-helix is considered central to its membrane interaction characteristics.
LL-37’s amphipathic alpha-helical structure has been characterized as central to its interaction with microbial membranes, and this membrane-active property has been the focus of extensive biophysical and microbiological investigation. In vitro studies have examined its interaction with bacterial membrane model systems, documenting that LL-37 adopts a surface-parallel orientation in oriented lipid bilayers and disrupts the membrane through a toroidal-pore mechanism, with this surface orientation maintained across both anionic and zwitterionic bilayer compositions [1]. Published research characterizing LL-37 as a chemoattractant for human neutrophils, monocytes and T cells acting through formyl peptide receptor-like 1 (FPRL1), and documenting calcium mobilization in FPRL1-transfected cells as evidence of the receptor mediating LL-37’s chemotactic signaling [2], and with in vivo wound-model research documenting that adenoviral delivery of LL-37 to excisional wounds in ob/ob (obese) mice significantly improved re-epithelialization and granulation tissue formation [3], making LL-37 a reference compound in innate-immunity and antimicrobial-peptide research examining membrane-active host defense peptide mechanisms and FPRL1-mediated immunomodulatory signaling in preclinical models.
LL-37 is produced to research-grade standards and independently verified by third-party HPLC and MS-UPLC analysis before dispatch. Vials are vacuum sealed and stored in a temperature controlled, monitored cold storage system. Certificates of Analysis are available to view and download directly on the product page.
Sold strictly for in vitro research purposes only. Not for human consumption. Intended for use by qualified researchers in laboratory settings only.
References
Scientific Review

Dr. Martina Rossi, PhD
Scientific Contributor and Reviewer
Reviewed for scientific accuracy, 11 August 2026
Lyophilised powder: store at -20 °C or below, away from light and moisture. Once reconstituted in an appropriate laboratory diluent (e.g. sterile water, PBS, or assay buffer), store at 2–8 °C and use within the validated period for your protocol. Do not refreeze.
What Researchers Say
Sign in to leave a reviewNo reviews yet. Be the first to share your research experience.
Frequently Asked Questions
Select Size
Quality Guaranteed
Every batch is HPLC-tested to ≥98% purity. Certificate of Analysis available on this page; MSDS available on request.






